Introduction
Previous studies have documented widespread iatrogenic underfeeding in intensive care unit (ICU) patients and that underfeeding was associated with worse clinical outcomes. [1] [2] [3] [4] [5] [6] Systematic barriers to adequate delivery of nutrition exist, many of which relate to the initiation of feeds and use of a feeding protocol. 7 Consequently, Heyland and colleagues 8 introduced a novel enteral feeding protocol designed to overcome the main barriers to adequate delivery of enteral nutrition (EN), the Enhanced Protein-Energy Provision via the Enteral Route Feeding Protocol (PEP uP protocol). The main features of this new protocol are using 24-hour volume goal rather than an hourly goal rate, enabling an option to initiate "trophic feeds" or a low volume of a concentrated feeding solution, use of a semielemental feeding solution instead of a standard polymeric solution, prophylactic use of protein supplements and motility agents, and setting a higher value for tolerated gastric residual volume (300 mL). The rationale and justification for these nutrition strategies was provided in previous publications.
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When combined with a nursing educational intervention and compared with a standard feeding protocol, the PEP uP protocol resulted in a 12%-15% increase in the amount of protein and calories received by patients in the context of a cluster randomized multicenter trial. 9 Whether the protocol could be implemented outside of the research settings and whether larger effects on nutrition intake could be accomplished in the "realworld" setting was unknown. Accordingly, we set out to disseminate awareness of this new protocol outside of the cluster trial and assist interested ICUs in making the changes necessary within their institution or healthcare system to implement this novel feeding protocol. The purpose of this article is to describe our experience with implementing this feeding protocol and the observed improvements in nutrition intake in patients admitted to participating ICUs compared with a concurrent control group in the real-world setting.
Methods
This study is a multicenter quality improvement initiative. In the context of our prior work, we had created a number of tools to facilitate the implementation of the PEP uP protocol in ICUs across Canada (see Table 1 ). In the summer of 2012, we disseminated awareness of a critical care nutrition quality improvement collaborative we were forming to assist sites in implementing the PEP uP protocol, called the PEP UP Collaborative. We invited ICUs from our known networks and prior participants in our studies.
To be eligible to join the collaborative, ICUs had to be able to identify a multidisciplinary team consisting of, at a minimum, the ICU dietitian, a physician, and a nurse champion. In addition, they had to be willing to implement all aspects of the PEP uP protocol. Interested sites were also provided with access to implementation tools and an educational DVD presentation to train their multidisciplinary team, access to a member of the Critical Care Nutrition team who coached them on protocol implementation, and access to an online discussion group around questions unique to the PEP-uP protocol. In addition, through funding provided by Nestlé Health Care Nutrition (North York, Ontario, Canada), 4 of the participating ICUs were selected to receive a site visit and presentation from a member of the Critical Care Nutrition team, a starter pack that included a 3-day/patient supply of Peptamen 1.5 and Beneprotein (Nestlé Health Science), and a tablet computer for use at the bedside to assist with nutrition monitoring using a novel electronic tool we had developed. We opted to use a semi-elemental solution as part of the PEP uP protocol as a strategy to maximize tolerance in the early stages of critical illness. This was intended to be a "safe start" solution in the broadest patient populations encountered in an ICU and could be changed or discontinued on review and reassessment by the clinical team in the days following admission. Through the fall and winter of 2012-2013, we held monthly conference calls with members of the collaborative. During these calls, tools were explicated, training on implementation was provided, barriers/problems were discussed, and sites were encouraged to ask questions and share experiences with other participating sites. In between calls, project staff were available by phone or email to participating sites, and we implemented an online discussion group. The control ICUs elected to participate in the 2013 survey of their own accord and received no support or intervention from the study team beyond that which was available to all participants of the international survey.
Data Collection
To evaluate the success of our collaborative, we used data collected from a large international multicenter observational study of nutrition practices in the ICU conducted in spring of 2013, the International Nutrition Survey 2013. The methods of this recurring survey are similar to previously published studies. 10, 11 Eligible patients were critically ill adult patients mechanically ventilated prior to ICU admission or within the first 48 hours, who stayed in the ICU for at least 72 hours. On the first day of the study (May 15, 2013) , sites screened all patients located in their ICU on that day and began collecting data on all eligible patients. Sites continued to screen each new patient admitted to the ICU, with the goal of identifying 20 consecutive eligible patients. As per usual clinical practice, the decision to implement a feeding protocol and initiate feeds occurred when clinically indicated at the site level. For the purposes of this evaluation, we included only patients who met the described eligibility criteria above. There may have been other patients-those who stayed less than 72 hours and were initiated on feeding protocols in both groups-that we did not include in this study, but these are not patients of interest given their short stays. In non-PEP uP sites, patient care, including the use of semi-elemental diets, protein supplements, gastric residual volume threshold, and so on, was not standardized or influenced at any point during this observational study.
For each patient, data collected included patient characteristics and ICU admission information, baseline nutrition assessment, daily nutrition data, and 60-day patient outcomes. Baseline nutrition assessment was not standardized across sites, but we did capture the total calories and protein prescribed and received. Prescribed calories and protein referred to the calories and protein provided by the goal feeding regimen determined at the initial assessment, using EN or parenteral nutrition (PN), according to the physician's or dietitian's recommendation. Daily nutrition data, which included the initial feeding strategy and type and amount of nutrition received, were collected from ICU admittance until ICU discharge or death, or for a maximum of 12 days. Patient outcomes at day 60 were collected in hospital and included the date mechanical ventilation was discontinued, ICU and hospital discharge, and mortality. Data were abstracted from patient records and entered online using a secure web-based electronic data capture system.
Statistical Approach
From the list of sites that participated in the international nutrition survey in 2013, we selected all other participating Canadian ICUs that used their existing feeding protocols to be part of a concurrent control group. We justify restricting our control group to other Canadian sites given that there are significant differences in nutrition performance based on geographic region. 12 In effect, we describe the success of implementing several aspects of the PEP uP protocol and compare nutrition outcomes (nutrition adequacy, time to starting EN, etc) between the PEP uP sites and the concurrent control group. Adequacy of EN refers to percent of prescribed calories and protein received from EN. Adequacy of total nutrition was expressed as the percent of caloric and protein prescriptions received from either EN or PN when there was a reported contraindication for EN, inclusive of propofol, during the first 12 days in ICU or until death or discharge from ICU, whichever came first. Days without EN or PN were included and counted as 0% adequacy while days after permanent progression to exclusive oral intake were excluded. Permanent progression to exclusive oral feeding occurred when a patient had begun oral feeding and subsequently did not receive any EN or PN during the remaining days of their data collection. Patients prescribed PN only were excluded from this analysis in both groups since they would not have received the PEP uP protocol.
Site and patient characteristics, patient outcomes, and nutrition variables (prescriptions, process variables, and adequacy) were compared between PEP uP sites and concurrent control sites. All categorical variables are described as counts and percentages. Continuous variables are described as means and standard deviations except for site characteristics, which are described as means and site ranges, and length of stay variables, which are summarized by medians and quartiles due to their positive skew. Between-group differences in nutrition adequacy and nutrition process variables were tested by the linear mixedeffect model with site as a random effect for continuous variables and by the Rao-Scott χ 2 clustered by site for categorical variables. 13, 14 Since nutrition intake increases over the first few days in the ICU, the linear mixed-effects model comparing nutrition adequacy between groups includes the number of evaluable nutrition days as a covariate. Baseline characteristics that were observed to differ substantially between the 2 groups were also included as covariates in the linear mixed-effects models.
All analysis used SAS version 9.3 (SAS Institute, Cary, NC). P values were not adjusted for multiplicity of tests. The Queen's University Research Ethics Board approved the International Nutrition Survey. Individual sites also obtained local research ethics board approvals as required by their local institutions.
Results
In 2013, there were 202 ICUs from 26 countries that participated in the International Nutrition Survey. Of the 24 sites from Canada, 8 were part of the PEP uP collaborative, and the remaining 16 served as concurrent control sites. Characteristics of participating sites are shown in Table 2 . Most participating hospitals were nonteaching hospitals with a "closed" administrative model of care. PEP uP sites tended to come from smaller hospitals and have fewer numbers of beds in their ICU compared with control sites. With respect to the feeding protocols used in control sites, the mean threshold value of gastric residual volumes was 257 mL (range, 200-400 mL).
In accordance with the International Nutrition Survey 2013, each site enrolled approximately 20 patients to evaluate the impact of their feeding protocols. Table 3 describes the baseline characteristics and clinical outcomes of patients included in this evaluation. Patients in control hospitals were more likely to have a surgical admission diagnosis and have a higher Acute Physiology and Chronic Health Evaluation II (APACHE II) score (Table 3) . Overall, 25% of study patients died by day 60. Among survivors, the median length of stay in the ICU and hospital was 11.0 days (interquartile range, 6.4-21.3) and 26.9 days (interquartile range, 13.9-57.3), respectively, and was not different between groups (Table 3) .
Differences in Nutrition Practice
Most patients received EN only (>85%), and a few patients received combined EN + PN (12% in PEP uP sites vs 8% in control hospitals). The amount of calories and protein received from EN and total nutrition by patients in sites using the PEP uP protocol was significantly greater than that in control sites (Table 4 and Figure 1 ). However, site performance varied greatly as the proportion of calories and protein provided from EN sources ranged from an average of 46.9%-83.4% in PEP uP sites and 31.7%-84.0% in control sites. From enteral sources, patients at PEP uP sites received 60.1% of their prescribed energy requirements compared with 49.9% in patients from control hospitals (P = .02). In addition, patients in PEP uP protocol sites received more protein (61.0% vs 49.7% of prescribed amounts; P = .01), were more likely to receive protein supplements (71.8% vs 47.7%; P = .01), and were more likely to receive >80% of their protein requirements by day 3 (46.1% vs 29.3%; P = .05) compared with patients in control hospitals. Patients in PEP uP protocol sites were also more likely to receive a semi-elemental or elemental solution (48% vs 8%; P < .001) and motility agents (55.0% vs 10.0%; P < .001) within 48 hours of admission. As measured by the proportion of glucose readings >10 mmol/L (180 mg/dL), there was no difference in glycemic control between the 2 groups (25% vs 19%; P = .28) ( Table 5) .
As illustrated in Figure 2 , if patients in PEP uP sites were initiated on volume-based feeds from the beginning of the ICU stay, they were much more likely to receive more protein and calories compared with patients started at a low rate or those started on trophic feeds. The proportions of received calories for patients who were nil per os (NPO) or had trophic, lowrate, and volume-based feeds were on average 29.9%, 52.5%, 65.1%, and 74.1%, respectively (P < .001); proportions of 
Discussion
In the context of a national quality improvement collaborative, we implemented the PEP uP protocol in several ICUs in Canada. We then compared their performance on several key nutrition parameters with other Canadian ICUs that participated in our International Nutrition Survey in 2013. We observed that nutrition practices and nutrition outcomes were superior in those sites that had implemented the PEP uP protocol compared with those that did not. Patients in PEP uP sites were more likely to receive supplemental protein, a semi-elemental solution, and a motility agent within 48 hours of admission to the ICU. In conjunction with volume-based feedings, these practices resulted in patients in PEP uP sites receiving more protein and energy compared with those in control sites (average 60.1% of their prescribed energy requirements compared with 49.9% [P = .02] and 61.0% vs 49.7% of prescribed protein amounts; P = .01). The magnitude of the improvements seen here is consistent with our prior work with implementing the PEP uP protocol in a single-center study and a multicenter cluster randomized trial. 8, 9 We note that compliance with all aspects of the PEP uP protocol is still imperfect (<100% of patients receiving protein supplements in the face of a cumulative protein debt, for example) and that there is tremendous variation in site performance (adequacy ranged from 46.9%-83.4% in PEP uP sites). These observations lead us to conclude that with more successful implementation of the various components of the PEP uP protocol, even greater success with nutrition delivery can be achieved. Key to success with delivering adequate amounts of protein and energy seem to be the ability to initiate patients on a volume-based feeding strategy from the very beginning and not keeping patients NPO. We are unsure if the observed benefits of the PEP uP protocol stem from the use of a semi-elemental or elemental solution as a starting strategy. Further work needs to be done to define whether the PEP uP protocol can be used with a standard polymeric solution and sites can achieve similar results. Moreover, can the increased nutrition performance be explained by a higher average gastric residual volume threshold in PEP uP sites compared with control sites? Again, we are not sure as to the exact component in the PEP uP protocol that is responsible for the greater nutrition delivery. It may be related to a higher gastric residual volume threshold, other factors, or all components working together. It is noteworthy that measuring gastric residual volumes at all has been challenged by a recent clinical trial demonstrating no benefit to measuring residual volumes, although the generalizability of the trial's findings has been questioned. 15, 16 Could it be the use of protein supplements that is responsible for increased nutrition performance? These supplements would have no effect on increased caloric intake, and there is still a considerable protein deficit in PEP uP patients. Finally, we also suspect that a feeding protocol alone may not be sufficient to overcome all barriers to feeding critically ill patients. There may be other structural or system-level barriers related to nutrition practices, such as access to products, dietitians, or devices; organizational culture and teamwork; and deprioritization of nutrition, to name a few, that cannot be overcome by simply adopting a feeding protocol.
The purpose of this project was not to demonstrate that increased nutrition adequacy could be causally related to improved clinical outcomes of critically ill patients. Our focus was on changing the healthcare system and how it delivers nutrition to a population of patients. We can appeal to other large-scale observational studies of nutritionally "high-risk" patients, 10, 17 randomized controlled trials of other strategies to enhance enteral nutrition delivery, 18, 19 and recent randomized trials of supplemental parenteral nutrition 20, 21 that show a positive effect of enhanced delivery of calories and protein on clinically important patient outcomes. Admittedly, the magnitude of the treatment effect of the PEP uP protocol, in terms of differences in protein and caloric intake, is smaller than the differences observed in these large-scale studies. Furthermore, the positive effect of enhanced nutrition delivery will not be seen in all critically ill patients. Not all critically ill patients experience the same outcome benefit from enhanced proteincalorie administration. This may explain why some trials fail to show an effect of enhanced nutrition intake and what led us to develop the NUTrition Risk in the Critically ill (NUTRIC) score. 22 This score was based on a conceptual model that linked starvation, inflammation, and nutrition status to clinical outcomes and may be useful in identifying those patients who will benefit the most from enhanced nutrition delivery. 23 When designing system-level tools, such as feeding protocols, we recommend using practices that maximize the benefits to the broadest groups of patients. Hence, we recommend that a PEP uP protocol (or similar approach) be used in all patients. 24 In contrast, implementing a feeding protocol that initiates trophic or low-volume enteral feeds in all patients will result in significant underfeeding in all patients, some of whom may be harmed by this approach. The strengths of this study include the reporting on the real-life experience of implementing a novel feeding protocol in multiple ICUs across Canada and the use of a standardized, validated data set to evaluate nutrition performance. These factors enhance the validity and the generalizability of our findings. However, we are uncertain how successful the feeding protocol may work in other countries with different healthcare systems that may present different barriers to adoption. Weaknesses of the study include the lack of randomization of sites. As with any observational study, some difference in patient and site characteristics may explain the differences in nutrition performance observed. However, we have previously shown in a randomized trial that this protocol can be successfully implemented in a large number of diverse settings. 9 The purpose of this specific initiative was to work with front-line clinicians (as opposed to research personnel) to implement and evaluate the novel protocol in the real-world setting (as opposed to the research setting). It may be that the differences in nutrition performance observed had to do with how the sites were managed as the PEP uP sites received training and support from the study team on protocol implementation, whereas the control group sites did not. However, we think this outside influence was less likely to have an impact on site feeding practices than the actual feeding protocol implemented. Finally, we still did observe variable levels of success with implementing the PEP uP protocol across sites, and no individualized assessment of barriers to EN delivery was performed.
In conclusion, we have demonstrated the ability to successfully implement a novel feeding protocol in ICUs across Canada. While implementation was less than perfect, we still observed significant improvements in nutrition practices and nutrition outcomes. We postulate that with greater attention to the implementation of components of the protocol (eg, motility agents and protein supplements) and the use of volume-based feedings, most critically ill patients will receive closer to prescribed amounts of protein and calories.
